Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ME3738

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Soyasapogenol, an aglycon of soyasaponin, ameliorates liver injury induced by concanavalin A in mice. A derivative of… Expand
  • table I
  • table II
  • figure 1
  • figure 2
  • figure 3
2014
2014
ME3738, a derivative of soyasapogenol B, enhances the anti‐hepatitis C virus (HCV) effect of interferon in an in vitro… Expand
2011
2011
BACKGROUND & AIMS ME3738 (22β-methoxyolean-12-ene-3β, 24-diol), a derivative of soyasapogenol B, attenuates liver disease in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2008
2008
Aim:  The aim of this study was to examine the preventive effects of ME3738 on hepatic fibrosis induced by bile duct ligation… Expand
2008
2008
A derivative of soyasapogenol, 22β‐methoxyolean‐12‐ene‐3β, 24(4β)‐diol (ME3738), ameliorates liver injury induced by Concanavalin… Expand
2007
2007
BACKGROUND Recently, ME3738, a derivative of soyasapogenol B, was developed as an inducer of interleukin (IL)-6. It has been… Expand
2007
2007
ME3738 (22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol), a derivative of soyasapogenol, attenuates liver disease in several… Expand
2006
2006
We examined whether the 22beta-methoxyolean-12-ene-3beta,24(4beta)-diol (ME3738)-mediated selective induction of interleukin-6… Expand
2003
2003
ME3738 is a new compound that attenuates liver disease in several models of acute and chronic liver inflammation. We used the… Expand